Clinical Trial

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The investigators aim to address the following specific aims: * Determine the efficacy of Prog in preventing postpartum smoking relapse and reducing smoking relapse risk factors. * Examine the effects of this maternal smoking intervention on infant health. * Examine racial and ethnic differences in intervention outcomes.
Trial Details
NCT Number NCT04783857
Lead Sponsor University of Minnesota
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Smoking, Smoking Cessation, Smoking Reduction
Enrollment 171 participants
Start Date 2022-04-14
Primary Completion 2027-06-02 (estimated)
Study Completion 2027-06-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-04